Cargando…

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

Background: Serum phosphate levels, which are associated with the progression of renal dysfunction in chronic kidney disease, in patients with autosomal dominant polycystic kidney disease (ADPKD) are lower than those in patients with other kidney diseases. However, their role in ADPKD remains unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masayo, Kataoka, Hiroshi, Ushio, Yusuke, Manabe, Shun, Watanabe, Saki, Akihisa, Taro, Makabe, Shiho, Yoshida, Rie, Iwasa, Naomi, Mitobe, Michihiro, Hanafusa, Norio, Tsuchiya, Ken, Nitta, Kosaku, Mochizuki, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151570/ https://www.ncbi.nlm.nih.gov/pubmed/32178226 http://dx.doi.org/10.3390/medicines7030013

Ejemplares similares

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes
por: Manabe, Shun, et al.
Publicado: (2021)

Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
por: Makabe, Shiho, et al.
Publicado: (2021)

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome
por: Akihisa, Taro, et al.
Publicado: (2019)

Machine learning for morbid glomerular hypertrophy
por: Ushio, Yusuke, et al.
Publicado: (2022)

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R(2) Values in Relation to Renal Outcomes
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease
por: Aoyama, Yumi, et al.
Publicado: (2020)

Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion
por: Watanabe, Saki, et al.
Publicado: (2019)

Time series changes in pseudo-R(2) values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance (MGRS)
por: Ino, Ayami, et al.
Publicado: (2019)

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease
por: Manabe, Shun, et al.
Publicado: (2021)

Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018)

Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis
por: Suzuki, Shunji, et al.
Publicado: (2020)

Glomerulopathy with Homozygous Apolipoprotein E2: A Report of Three Cases and Review of the Literature
por: Kawanishi, Kunio, et al.
Publicado: (2013)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining
por: Sato, Masayo, et al.
Publicado: (2021)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance
por: Mochizuki, Toshio, et al.
Publicado: (2021)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ct7jrmitj45eavp8ma96ltd78q